CyanConnode Holdings plc (LON:CYAN) has steadily been making progress in India, where the national smart meter programme has been gathering pace. In July 2022, the company crossed the one million
In our recent note, Eight questions for the AGM on 10 May 2022 | Hardman & Co (hardmanandco.com), we touched on the rapidly changing landscape after the extraordinary bull run
CyanConnode Holdings plc (LON:CYAN) has steadily been making progress in India, where the national smart meter programme has been gathering pace. In July 2022, the company crossed the one million
Advanced Oncotherapy plc (LON:AVO) goal is to deliver an affordable and novel PT system, called LIGHT, based on state-of-the-art technology, developed originally at the world-renowned CERN. The complex assembly of
Tissue Regenix Group plc (TRX) is focused on the development and commercialisation of two proprietary processing technologies for the repair of soft tissue (dCELL) and bone (BioRinse). It has a broad
Volta Finance Ltd (LON:VTA) is no different from any other investment company in that it identifies when the market has mispriced long-term cashflows. In this note, we examine its success
We believe a significant driver to the whole listed PE sector trading at a large discount to NAV is investors’ concerns about whether the NAVs are real and conservative, and
Shield Therapeutics plc (LON:STX) is a commercial-stage pharma company delivering specialty products that address patients’ unmet medical needs, with an initial focus on iron deficiency (ID). Following launch of Accrufer® in
Chesnara plc (LON:CSN) has announced its 2022 half-year results. With weak equity markets and rising interest rates and credit spreads, the risk asset exposure weighed on results. Economic Value profit
1H’22 results from Neodecortech (NDT) continued the trend of FY’21. Total revenue was up 20% compared with 1H’21, to a record €103m, demonstrating the continued strength of NDT’s new products
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
